References
- van Leeuwen F. E., Swerdlow A. J., Valagussa P., Tucker M. A. Second cancer after treatment of Hodgkin's disease. Hodgkin's Disease, P. M. Mauch, J. O. Armitage, V. Diehi, R. T. Hoppe, L. M. Weiss. Lippincott Williams & Wilkins, Philadelphia 1999; 607–632
- Juhasz L. Cancer Incidence in the County Szabolcs-Szatmar-Bereg, Hungary 1990–91. Cancer Series No 14, Nyiregyhaza 1993
- Munker R., Hiller E., Melnyk A., Gutjahr P. Second malignancies: clinical relevance and basic research (review). Int. J. Oncol. 1996; 9: 763–776
- Wolden S. L., Lamborn K. R., Cleary S. F., Tate D. J., Donaldson S. S. Second cancers following pediatric Hodgkin's disease. J. Clin. Oncol. 1998; 16(2)536–544
- Henry-Aimar M., Somers R. Survival outcome after Hodgkin's disease: a report from the international data base on Hodgkin's disease. Semin. Oncol. 1990; 17: 758–768
- Brierley J. D., Rathmell A. J., Gospodarowicz M. K., et al. Late effects of treatment for early-stage Hodgkin's disease. Br. J. Cancer 1998; 77: 1300–1310
- Rodriguez M. A., Fuller L. M., Zimmerman S. O., et al. Hodgkin's disease: study of treatment intensities and incidences of second malignancies. Ann. Oncol. 1993; 4: 125–131
- Abrahamsen J. F., Andersen A., Hannisdal E., et al. Second malignancies after treatment of Hodgkin's disease: the influence of treatment. Follow-up time, and age. J. Clin. Oncol. 1993; 11: 255–261
- Tura S., Fiacchini M., Zinzani P. L., Brusamolino E., Gobbi P. G. Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. J. Clin. Oncol. 1993; 11: 925–930
- Armitage J. O. Long-term toxicity of the treatment of Hodgkin's disease. Ann. Oncol. 1998; 9: S133-S136
- Hess C. F., Kortmann R. D., Schmidberger H., Bamberg M. How relevant is secondary leukaemia for initial treatment selection in Hodgkin's disease?. Eur. J. Cancer 1994; 10: 1441–1447
- Hoppe R. T. Long-term complications of treatment for Hodgkin's disease. Trends Onco-Hematol. 1996; 4(3)46–48
- Boffetta P., Kaldor J. M. Secondary malignancies following cancer chemotherapy. Acta Oncol. 1994; 33(6)591–598
- Mauch P. M., Chalice L. A., Marcus K. C., et al. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood 1996; 87(9)3625–3632
- Henry-Amar M., Somers R. Survival outcome after Hodgkin's disease: a report from the international data base on Hodgkin's disease. Semin. Oncol. 1990; 17(6)758–768
- Boivin J. F., Hutchison G. B., Zauber A. G., et al. Incidence of second cancer in patients treated for Hodgkin's disease. J. Nat. Cancer Inst. 1995; 87(10)732–734
- Swerdlow A. J., Barber J. A., Horwich A., Cunningham D., Milan S., Omar R. Z. Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. Br. J. Cancer 1997; 75: 116–123
- Salloum E., Doria R., Schubert W., et al. second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J. Clin. Oncol. 1996; 9: 2435–2443
- Epstein R., Hanham I., Dale R. Radiotherapy-induced second cancers: we doing enough to protect young patients?. Eur. J. Cancer 1997; 4: 526–530
- Sears J. D., Greven K. M., Ferree C. R., D'Agostino R. B. Definitive irradiation in the treatment of Hodgkin's disease. Cancer 1997; 79: 145–151
- Wolf J., Schellong G., Diehl V. Breast cancer following treatment of Hodgkin's disease—more reasons for less radiotherapy?. Eur. J. Oncol. 1997; 33(14)2293–2294
- Aisenberg A. C., Finkelstein D. M., Doppke K. P., Koerner F. C., Boivin J. F., Willett C. G. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer 1997; 79: 1203–1210
- van Leeuwen F. E., Klokman W. J., Hagenbeek A., et al. second cancer risk following Hodgkin's disease: a 20-year follow-up study. J. Clin. Oncol. 1994; 12(2)312–325
- Ill O. B., Hudson M. M., Greenwald C., et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J. Clin. Oncol. 1995; 3: 603–609
- Bhatia S., Robinson L. L., Oberlin O., et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N. Engl. J. Med. 1996; 334(12)745–750
- Sankila R., Garwicz S., Olsen J. H., et al. Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five nordic countries. J. Clin. Oncol. 1996; 14(5)1442–1446
- Zatonski W., Smans M., Tyczynski J., Boyle P. Atlas of cancer mortality in Central Europe. ARC Scientific Publications, Lyon 1996; 134: 30–31